Bayesian Design for Identifying Cohort-Specific Optimal Dose Combinations Based on Multiple Endpoints: Application to a Phase I Trial in Non-Small Cell Lung Cancer
Immunotherapy and chemotherapy combinations have proven to be a safe and efficacious treatment approach in multiple settings. However, it is not clear whether approved doses of chemotherapy developed to achieve a maximum tolerated dose are the ideal dose when combining cytotoxic chemotherapy with im...
Saved in:
Main Authors: | Bethany Jablonski Horton, Nolan A. Wages, Ryan D. Gentzler |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c21c28f4d5fd4bdf9cf2b2ccf3e2a83f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
by: Lerner SF, et al.
Published: (2019) -
The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children
by: John M. VanBuren, et al.
Published: (2021) -
Clinical and pharmacological approaches to the choice of a drug for a tension-type headache relief
by: Evgeniya V. Shikh, et al.
Published: (2021) -
Combine therapy as a modern approach to treatment of allergic rhinitis
by: Alexander V. Emelyanov
Published: (2021) -
Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic
by: Dénes Csonka, et al.
Published: (2021)